DOI: 10.1055/s-00000069

Seminars in Liver Disease


Okita K, Imanaka K, Chida N , et al.
Phase III study of sorafenib in patients in Japan and Korea with advanced hepatocellular carcinoma (HCC) treated after transarterial chemoembolization (TACE).
Abstract presented at the 2010 Gastrointestinal Cancers Symposium; January 22–24, 2010; Orlando, FL

Download Bibliographical Data

Search in: